etoposide has been researched along with Liver Diseases in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruno, B; Chalandon, Y; Charbonnier, A; Coiteux, V; Simon, N; Souchet, L; Taque, S; Vincent, L; Yakoub-Agha, I | 1 |
| Dumas, I; Ferrer, L; Guillem, P; Lattuca-Truc, M; Levra, MG; Moro-Sibilot, D; Pinsolle, J; Ruckly, S; Timsit, JF; Toffart, AC; Villa, J | 1 |
| Barber, L; Clay, J; Devlia, V; Feliu, J; Mufti, G; Pagliuca, A; Raj, K; Shaw, B | 1 |
| Abe, T; Fujita, K; Kimakura, M; Kiuchi, H; Nagahara, A; Nonomura, N; Uemura, M | 1 |
| Katayama, N; Miyazaki, K; Monma, F; Nakase, K; Nishii, K; Tawara, I; Ueno, S; Yamaguchi, M | 1 |
| Ballen, K; Becker, PS; Clark, Y; Emmons, RV; Levy, W; Liu, Q; Rossi, HA; Westervelt, P | 1 |
| Abbott, BL; Chen, R; Myint, H | 1 |
| Couzi, R; Holdhoff, M; Petronis, JD; Wung, PK | 1 |
| Betsuyaku, T; Hizawa, N; Koizumi, T; Konno, S; Nishimura, M; Yamamoto, H; Yasuo, M | 1 |
| Greco, FA; Johnson, DH; Wolff, SN | 1 |
| Kueh, YK; Ong, ST | 1 |
| Bostrom, BC; Dehner, LP; Freyer, DR; Kennedy, R; Kohut, G | 1 |
| Dittert, DD; Fischer, R; Gerlach, B; Richter, G; Stein, A; Wozel, G | 1 |
| al-Ramadi, B; Ellis, M; Gorka, W; Shamoon, A; Zwaan, F | 1 |
| Dass, C; Desiderio, DM; Evans, R; Nemec, J; Relling, MV | 1 |
| Cavalli, F; D'Incalci, M; Mangioni, C; Rossi, C; Sessa, C; Urso, R; Willems, Y; Zucchetti, M | 1 |
2 review(s) available for etoposide and Liver Diseases
| Article | Year |
|---|---|
[Dose adaptation of the drugs used for hematopoietic stem-cell transplantation in patients with comorbidity: Obesity, chronic renal disease or hepatopathy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-T
Topics: Adult; Age Factors; Busulfan; Child; Comorbidity; Cyclophosphamide; Etoposide; France; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Liver Diseases; Melphalan; Obesity; Renal Insufficiency, Chronic; Societies, Medical; Surveys and Questionnaires; Thiotepa; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation | 2017 |
Juvenile xanthogranuloma: forms of systemic disease and their clinical implications.
Topics: Anti-Inflammatory Agents; Brain Diseases; Child; Child, Preschool; Cyclosporine; Etoposide; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Liver Diseases; Lung Diseases; Male; Prednisone; Remission, Spontaneous; Skin; Splenic Diseases; Survival Rate; Treatment Outcome; Vinblastine; Xanthogranuloma, Juvenile | 1996 |
1 trial(s) available for etoposide and Liver Diseases
| Article | Year |
|---|---|
High-dose cyclophosphamide, BCNU, and VP-16 (CBV) conditioning before allogeneic stem cell transplantation for patients with non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Blood Platelets; Carmustine; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infections; Liver Diseases; Lung Diseases; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutrophils; Recurrence; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2003 |
13 other study(ies) available for etoposide and Liver Diseases
| Article | Year |
|---|---|
Trends in response rate and survival in small-cell lung cancer patients between 1997 and 2017.
Topics: Aged; Bridged-Ring Compounds; Cardiovascular Diseases; Etoposide; Female; France; Humans; Liver Diseases; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Platinum Compounds; Prognosis; Small Cell Lung Carcinoma; Survival Analysis; Taxoids | 2019 |
Transplant-acquired food allergy (TAFA) following cord blood stem cell transplantation in two adult patients with haematological malignancies.
Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Cytarabine; Daunorubicin; Drug Therapy, Combination; Egg Hypersensitivity; Etoposide; Female; Food Hypersensitivity; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Immunosuppressive Agents; Intestinal Diseases; Leukemia, Myeloid, Acute; Liver Diseases; Male; Middle Aged; Nut Hypersensitivity; Seafood; Tacrolimus; Transplantation Conditioning; Vidarabine | 2014 |
Metastatic testicular cancer presenting with liver and kidney dysfunction treated with modified BEP chemotherapy combined with continuous hemodiafiltration and rasburicase.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Endodermal Sinus Tumor; Etoposide; Hemodiafiltration; Humans; Kidney Diseases; Liver Diseases; Male; Neoplasm Metastasis; Testicular Neoplasms; Tumor Lysis Syndrome; Urate Oxidase | 2016 |
[Long-term remission of a nasal NK/T-cell lymphoma patient with massive involvement of the orbita and liver dysfunction].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Humans; Liver Diseases; Lymphoma, Extranodal NK-T-Cell; Middle Aged; Neoplasm Invasiveness; Nose Neoplasms; Orbital Neoplasms; Radiotherapy Dosage; Remission Induction; Time Factors; Treatment Outcome | 2009 |
Treatment of HIV-associated Burkitt Lymphoma in the presence of severe hepatic dysfunction.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; HIV Infections; Humans; Liver Diseases; Male; Prednisone; Remission Induction; Vincristine | 2006 |
Persistent positron emission tomography-positive liver lesions after successful chemotherapy in mediastinal seminoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Liver Diseases; Liver Neoplasms; Male; Mediastinal Neoplasms; Neoplasm, Residual; Positron-Emission Tomography; Seminoma | 2007 |
Adult Langerhans cell histiocytosis with independently relapsing lung and liver lesions that was successfully treated with etoposide.
Topics: Adult; Antineoplastic Agents, Phytogenic; Biopsy; Etoposide; Histiocytosis, Langerhans-Cell; Humans; Liver; Liver Diseases; Lung; Lung Diseases; Male; Secondary Prevention | 2007 |
Etoposide-induced hepatic injury: a potential complication of high-dose therapy.
Topics: Adult; Chemical and Drug Induced Liver Injury; Etoposide; Humans; Liver Diseases; Liver Function Tests; Male; Neoplasms, Germ Cell and Embryonal; Podophyllotoxin | 1983 |
Hepatic candidiasis: persistent pyrexia in a patient with acute myeloid leukaemia after recovery from consolidation therapy-induced neutropenia.
Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Candidiasis; Cytosine; Etoposide; Fever; Fluconazole; Focal Infection; Humans; Leukemia, Myelomonocytic, Acute; Liver Diseases; Male; Neutropenia; Remission Induction; Tomography, X-Ray Computed | 1993 |
[Langerhans cell histiocytosis in the elderly].
Topics: Adult; Aged; Child, Preschool; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Immunoenzyme Techniques; Liver Diseases; Mechlorethamine; Microscopy, Electron; Recurrence; Skin; Treatment Failure | 1998 |
Severe hepatic injury associated with lipid formulations of amphotericin B.
Topics: Adolescent; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Cytarabine; Etoposide; Female; Humans; Idarubicin; Leukemia, Myeloid; Liposomes; Liver; Liver Diseases | 2001 |
Human cytochrome P450 metabolism of teniposide and etoposide.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Etoposide; Female; Humans; Infant; Kinetics; Liver Diseases; Male; Microsomes, Liver; Middle Aged; Teniposide | 1992 |
Pharmacokinetics of etoposide in patients with abnormal renal and hepatic function.
Topics: Adult; Aged; Etoposide; Female; Humans; Kidney Diseases; Liver Diseases; Male; Metabolic Clearance Rate; Middle Aged; Podophyllotoxin | 1986 |